Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04289922
Other study ID # REK 2019/428 A
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 8, 2019
Est. completion date August 5, 2022

Study information

Verified date November 2022
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to translate, cross-cultural adapt and validate the Norwegian VISA-G (VISA-N-G) questionnaire. The study will test the psychometric properties for the VISA-N-G in terms of test-retest reliability, internal consistency, construct validity and responsiveness.


Description:

The Victorian Institute of Sport Assessment-Gluteal Questionnaire (VISA-G) questionnaire have already been developed and used as a measurement tool in research on English speaking Greater trochanteric pain syndrome (GTPS) populations. The aim of this study is to translate, cross-cultural adapt and validate the Norwegian VISA-G (VISA-N-G) questionnaire. The translation of the original VISA-G into Norwegian has been done following the official guidelines. The patients will be recruited from the outpatient clinic at the Department of Physical Medicine and Rehabilitation, Oslo University Hospital and will follow the ordinary patient care. After given written consent, patients will be asked to fill out the following Norwegian questionnaires: VISA-N-G, Harris Hip Score (HHS), Oswestry disability index (ODI) and a numeric rating scale (NRS) for assessment of pain intensity. The aforementioned questionnaires will be used to test the construct validity with various hypothesis at baseline. Within one week the investigators will ask the patients to fill out the VISA-N-G once more to test the test-retest reliability. To investigate responsiveness the patient will be asked to fill out the VISA-N-G together With HHS, ODI, NRS and a 11-Point Global Rating of Change scale (GROC) after seven weeks. Responsiveness will be tested with various hypothesis and measured by the area under the receiver operating characteristics curve (ROC).


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date August 5, 2022
Est. primary completion date August 5, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Hip pain - Ability to read and write Norwegian - > 18 years old Exclusion criteria: - Not able to read and write Norwegian - < 18 years old

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

References & Publications (4)

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91. doi: 10.1097/00007632-200012150-00014. No abstract available. — View Citation

Fearon AM, Ganderton C, Scarvell JM, Smith PN, Neeman T, Nash C, Cook JL. Development and validation of a VISA tendinopathy questionnaire for greater trochanteric pain syndrome, the VISA-G. Man Ther. 2015 Dec;20(6):805-13. doi: 10.1016/j.math.2015.03.009. Epub 2015 Apr 2. — View Citation

Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010 May;19(4):539-49. doi: 10.1007/s11136-010-9606-8. Epub 2010 Feb 19. — View Citation

Nilsdotter A, Bremander A. Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire. Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S200-7. doi: 10.1002/acr.20549. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary VISA-N-G The Victorian Institute of Sport Assessment-Gluteal Questionnaire (VISA-G) questionnaire have already been developed and used as a measurement tool in research on English speaking GTPS populations.The VISA-G questionnaire is based on other Health-related patient-reported outcomes (HR-PROs) from Victorian Institute of Sports tendon study Group. The investigators will test the construct validity with two other HR-PROs (Harris Hip Score and Oswestry disability index). To investigate test-retest reliability, the patients will fill out a second VISA-N-G one week after baseline. To test responsiveness, the patients will fill out VISA-N-G 7 weeks after baseline together with the two other HR-PROs, and a Global Rating of Change scale. Baseline, 1 week, 7 weeks.
Secondary Harris Hip Score Harris Hip Score (HHS) is an HR-PROs questionnaire used for assessing outcome after total hip replacement, femoral neck fractures and osteoarthritis. It is expected to take 5 minutes to complete and is based on 10 items. It is scored from 0 to 100, where 100 is the best outcome, <70 is considered a poor result. HHS has shown to be a responsive measure and shows a strong correlation in the physical domain of The short form Health survey (SF36) and high correlation to the Nottingham Health Profile. Baseline, 7 weeks
Secondary Oswestry disability index Oswestry disability index (ODI) is a widely used HR-PROs used for spinal disorders. Its asking about the patients perceived disability and is scored from 0 to 100%, where 0% indicates no disability and 100% indicates most disability. ODI is cross-cultural adapted into Norwegian and psychometric properties was concluded acceptable for assessing self-reported functional status of Norwegian-speaking patients with low back pain. Baseline, 7 weeks
Secondary Numeric rating scale In a Numeric rating scale (NRS) the patients rate their pain intensity between 0 and 10. Zero represents "no pain at all" and 10 represents "the worst pain ever possible". NRS correlates highly to other pain assessment tools. A change of two points is detected as being clinically significant. In this project the investigator will ask for the patient's current pain, average pain the last week, worst pain last week, and least pain last week. Baseline, 7 weeks
Secondary Global Rating of Change scale A Global Rating of Change scale (GROC) scale is designed to quantify a patient's improvement or worsening over time, the scale ask about the current and previous health status and then calculates the difference. The scale is "global" and allows the patient themselves to subjectively decide their health status. Scales between 7 and 11 seems to be the compromise between patient preference, adequate discriminative ability and test-retest reliability. The investigator will use an 11-point scale from - 5 to 5 where - 5 = worsening, 0 = unchanged and 5 = completely recovered. An 11-point scale has shown test-retest reliability with ICC 0.90, minimum detectable change of 0.45 points and minimally clinically important change 2 points. Baseline, 7 weeks
See also
  Status Clinical Trial Phase
Completed NCT03590145 - Reliability of the Doha Agreement Classification of Groin Pain
Completed NCT06083428 - Erector Spinae vs. PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05551000 - Functional Training to Improve Everyday Performance in Elderlies N/A
Recruiting NCT05868369 - The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy N/A
Completed NCT04211987 - Fast Track Total Hip Arthroplasty vs Standard Care N/A
Recruiting NCT04736641 - Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire
Completed NCT02947178 - Hip Arthroscopy Pain Control Randomized Control Trial (RCT) Phase 4
Recruiting NCT03985280 - Radiofrequency Versus Intraarticular Local Anesthestic and Steroids Injection for Chronic Hip Pain. Phase 4
Completed NCT05944380 - PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05261009 - PENG Block Versus LP Block for THA Postop Pain Phase 4
Recruiting NCT05022381 - Treatment of Chronic Hip Pain by Application of Conventional Radiofrequency Thermocoagulation to the Articular Branches of the Femoral and Obturatory Nerve N/A
Recruiting NCT05853640 - Education and Exercise for Patients With Longstanding Hip and Groin Pain N/A
Completed NCT03248934 - Patient Performed Examination for Patients With Intra-articular Hip Pain N/A
Completed NCT03720821 - Cognitive Flexibility Training for Persistent Pain: Neuroimaging Pilot (COFLEX-i) N/A
Completed NCT04393909 - Improving Safety of Diagnosis and Therapy in the Inpatient Setting N/A
Recruiting NCT04027140 - MDR - M/L Taper With Kinectiv Technology Stems and Necks
Recruiting NCT03490071 - Long-term Follow up of Patients With Longstanding Hip and Groin Pain
Recruiting NCT04028687 - MDR - PMCF Study for Taperloc Complete Stems
Recruiting NCT03576625 - Effect of Buglossoides Oil on Recent Chronic Non-injurious Hip and Knee Pain Phase 1
Recruiting NCT06221709 - Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial. N/A